FDA Gets No Compounder Oversight Without Doc Release: GOP
Republican leaders investigating the recent meningitis outbreak's link to pharmacy compounding have warned the U.S. Food and Drug Administration's commissioner that without extensive internal agency documents, they could not grant the...To view the full article, register now.
Already a subscriber? Click here to view full article